In recognition of National Diabetes Awareness, The Daily Transcript looks at how local companies are finding ways to combat diabetes. Contact us at contact@sddt.com to get more involved.
| < previous | 1 2 3 4 | more stories > |
BRUSSELS, BELGIUM -- One in 10 of the world's population will have diabetes by 2035, according to the International Diabetes Federation. The latest edition of IDF Diabetes Atlas, published Thursday on World Diabetes Day, estimates that people living with diabetes will surge from 382 million to 592 million people by 2035, many in low- and middle-income countries and the majority under age 60. This surge will form the backdrop of the World Diabetes Congress in Melbourne, Australia, this December.
Shares of Tandem Diabetes Care Inc. soared in their first day of trading as a public company.
Shares of DexCom jumped Thursday after the medical device maker's third-quarter sales surpassed Wall Street forecasts.
Oct. 23 (Bloomberg) -- Eli Lilly & Co., which may introduce five new drugs next year, reported third-quarter profit that beat analysts’ estimates on cost cuts and higher sales of diabetes products.
San Diego-based Elcelyx Therapeutics has completed a 12-week Phase 2b study of NewMet, a delayed-release formulation of metformin for the treatment of patients with type 2 diabetes.
Kaiser Permanente San Diego has earned The Joint Commission's Gold Seal of Approval for its inpatient diabetes care program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care.
NEW YORK (AP) -- Shares of Lexicon Pharmaceuticals surged Tuesday after the company reported successful trial results for a diabetes drug intended for patients with kidney impairment.
Sept. 27 (Bloomberg) -- Medtronic Inc. the world’s largest maker of heart-rhythm devices, won U.S. regulatory approval for the first artificial pancreas that shuts itself off when a patient’s blood sugar levels get dangerously low.
Sept. 4 (Bloomberg) -- China’s diabetes epidemic is worse than previously estimated -- much worse.
Genalyte Inc. has announced it is collaborating with the Barbara Davis Center for Childhood Diabetes at the University of Colorado School of Medicine to further develop and test multiplexed antigen panels for the early detection of Type 1 diabetes.
VALENCIA, Calif. (AP) -- Drug developer MannKind says its inhaled insulin Afrezza met the main goals behind two late-stage studies involving patients with two types of diabetes.
WASHINGTON (AP) -- The Food and Drug Administration is cracking down on more than a dozen companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription drugs sold online without a prescription.
| < previous | 1 2 3 4 | more stories > |
John Gomez chats about his law firm and why they are different from other San Diego personal injury law firms.
 |
 |
 |
 |
 |